x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
France | Not Applicable | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) | |
32, rue Blanche, Paris-France | 75009 | |
(Address of principal executive offices) | (Zip Code) |
Large Accelerated Filer | x | Accelerated Filer | ¨ |
Non-accelerated Filer | ¨ (Do not check if a smaller reporting company) | Smaller reporting company | ¨ |
Emerging growth company | ¨ |
• | the ability of the Criteo Engine to accurately predict engagement by a user; |
• | our ability to predict and adapt to changes in widely adopted industry platforms and other new technologies; |
• | our ability to continue to collect and utilize data about user behavior and interaction with advertisers; |
• | our ability to acquire an adequate supply of advertising inventory from publishers on terms that are favorable to us; |
• | our ability to meet the challenges of a growing and international company in a rapidly developing and changing industry, including our ability to forecast accurately; |
• | our ability to maintain an adequate rate of revenue growth and sustain profitability; |
• | our ability to manage our international operations and expansion and the integration of our acquisitions; |
• | the effects of increased competition in our market; |
• | our ability to adapt to regulatory, legislative or self-regulatory developments regarding internet privacy matters; |
• | our ability to protect users’ information and adequately address privacy concerns; |
• | our ability to enhance our brand; |
• | our ability to enter new marketing channels and to effectively scale our technology platform in new industry verticals; |
• | our ability to attract and retain qualified employees and key personnel; |
• | our ability to maintain, protect and enhance our brand and intellectual property; and |
• | failures in our systems or infrastructure. |
Notes | December 31, 2016 | March 31, 2017 | |||||||
(in thousands) | |||||||||
Assets | |||||||||
Current assets: | |||||||||
Cash and cash equivalents | 3 | $ | 270,317 | $ | 303,813 | ||||
Trade receivables, net of allowances | 4 | 397,244 | 340,837 | ||||||
Income taxes | 2,741 | 3,560 | |||||||
Other taxes | 52,942 | 44,834 | |||||||
Other current assets | 5 | 19,340 | 22,772 | ||||||
Total current assets | 742,584 | 715,816 | |||||||
Property, plant and equipment, net | 108,581 | 115,415 | |||||||
Intangible assets, net | 6 | 102,944 | 107,962 | ||||||
Goodwill | 7 | 209,418 | 232,138 | ||||||
Non-current financial assets | 3 | 17,029 | 19,857 | ||||||
Deferred tax assets | 30,630 | 46,201 | |||||||
Total non-current assets | 468,602 | 521,573 | |||||||
Total assets | $ | 1,211,186 | $ | 1,237,389 | |||||
Liabilities and shareholders' equity | |||||||||
Current liabilities: | |||||||||
Trade payables | $ | 365,788 | $ | 295,602 | |||||
Contingencies | 14 | 654 | 980 | ||||||
Income taxes | 14,454 | 14,969 | |||||||
Financial liabilities - current portion | 9 | 7,969 | 84,398 | ||||||
Other taxes | 44,831 | 41,414 | |||||||
Employee - related payables | 55,874 | 53,862 | |||||||
Other current liabilities | 8 | 30,221 | 35,032 | ||||||
Total current liabilities | 519,791 | 526,257 | |||||||
Deferred tax liabilities | 686 | 28,900 | |||||||
Retirement benefit obligation | 3,221 | 3,276 | |||||||
Financial liabilities - non current portion | 9 | 77,611 | 2,620 | ||||||
Other non-current liabilities | — | 4,697 | |||||||
Total non-current liabilities | 81,518 | 39,493 | |||||||
Total liabilities | 601,309 | 565,750 | |||||||
Commitments and contingencies | |||||||||
Shareholders' equity: | |||||||||
Common shares, €0.025 per value, 63,978,204 and 64,665,637 shares authorized, issued and outstanding at December 31, 2016 and March 31, 2017, respectively. | 2,093 | 2,112 | |||||||
Additional paid-in capital | 488,277 | 514,649 | |||||||
Accumulated other comprehensive (loss) | (88,593 | ) | (79,742 | ) | |||||
Retained earnings | 198,355 | 222,239 | |||||||
Equity-attributable to shareholders of Criteo S.A. | 600,132 | 659,258 | |||||||
Non-controlling interests | 9,745 | 12,381 | |||||||
Total equity | 609,877 | 671,639 | |||||||
Total equity and liabilities | $ | 1,211,186 | $ | 1,237,389 |
Three Months Ended | |||||||||
Notes | March 31, 2016 | March 31, 2017 | |||||||
(in thousands, except share per data) | |||||||||
Revenue | $ | 401,253 | $ | 516,667 | |||||
Cost of revenue: | |||||||||
Traffic acquisition costs | (238,755 | ) | (306,693 | ) | |||||
Other cost of revenue | (18,338 | ) | (27,155 | ) | |||||
Gross profit | 144,160 | 182,819 | |||||||
Operating expenses: | |||||||||
Research and development expenses | (27,162 | ) | (39,521 | ) | |||||
Sales and operations expenses | (64,473 | ) | (90,730 | ) | |||||
General and administrative expenses | (24,737 | ) | (31,516 | ) | |||||
Total operating expenses | (116,372 | ) | (161,767 | ) | |||||
Income from operations | 27,788 | 21,052 | |||||||
Financial income (expense) | 11 | (1,317 | ) | (2,333 | ) | ||||
Income before taxes | 26,471 | 18,719 | |||||||
Provision for income taxes | 12 | (7,944 | ) | (4,201 | ) | ||||
Net income | $ | 18,527 | $ | 14,518 | |||||
Net income available to shareholders of Criteo S.A. | $ | 17,131 | $ | 12,442 | |||||
Net income available to non-controlling interests | $ | 1,396 | $ | 2,076 | |||||
Net income allocated to shareholders of Criteo S.A. per share: | |||||||||
Basic | 13 | $ | 0.27 | $ | 0.19 | ||||
Diluted | 13 | $ | 0.26 | $ | 0.18 | ||||
Weighted average shares outstanding used in computing per share amounts: | |||||||||
Basic | 13 | 62,610,013 | 64,189,194 | ||||||
Diluted | 13 | 64,841,134 | 67,283,012 |
Three Months Ended | ||||||||
March 31, 2016 | March 31, 2017 | |||||||
(in thousands) | ||||||||
Net income | $ | 18,527 | $ | 14,518 | ||||
Foreign currency translation differences, net of taxes | 20,689 | 9,092 | ||||||
Foreign currency translation differences | 20,689 | 9,092 | ||||||
Income tax effect | — | — | ||||||
Actuarial (losses) gains on employee benefits, net of taxes | (200 | ) | 253 | |||||
Actuarial losses on employee benefits | (238 | ) | 297 | |||||
Income tax effect | 38 | (44 | ) | |||||
Financial instruments, net of taxes | — | — | ||||||
Fair value change on financial instruments | — | — | ||||||
Income tax effect | — | — | ||||||
Comprehensive income (loss) | $ | 39,016 | $ | 23,863 | ||||
Attributable to shareholders of Criteo S.A. | $ | 37,245 | $ | 21,293 | ||||
Attributable to non-controlling interests | $ | 1,771 | $ | 2,570 |
Three Months Ended | ||||||||
March 31, 2016 | March 31, 2017 | |||||||
(in thousands) | ||||||||
Net income | $ | 18,527 | $ | 14,518 | ||||
Non-cash and non-operating items | 29,506 | 41,473 | ||||||
- Amortization and provisions | 13,180 | 22,316 | ||||||
- Equity awards compensation expense (1) | 8,370 | 14,940 | ||||||
- Interests accrued and non-cash financial income and expenses | 12 | 16 | ||||||
- Change in deferred taxes | (1,138 | ) | (6,870 | ) | ||||
- Income tax for the period | 9,082 | 11,071 | ||||||
Change in working capital requirement | (17,140 | ) | (70 | ) | ||||
- Decrease in trade receivables | 4,758 | 59,569 | ||||||
- Decrease in trade payables | (13,906 | ) | (75,030 | ) | ||||
- (Increase)/Decrease in other current assets | (10,368 | ) | 8,253 | |||||
- Increase in other current liabilities | 2,376 | 7,138 | ||||||
Income taxes paid | (11,986 | ) | (11,683 | ) | ||||
Cash from operating activities | 18,907 | 44,238 | ||||||
Acquisition of intangibles assets, property, plant and equipment | (13,615 | ) | (23,267 | ) | ||||
Change in accounts payable related to intangible assets, property, plant and equipment | 1,507 | (4,939 | ) | |||||
Change in other financial non-current assets | 781 | (431 | ) | |||||
Cash used in investing activities | (11,327 | ) | (28,637 | ) | ||||
Issuance of long-term borrowings | 764 | — | ||||||
Repayment of borrowings | (1,503 | ) | (2,053 | ) | ||||
Proceeds from capital increase | 5,476 | 12,937 | ||||||
Change in other financial liabilities | — | 119 | ||||||
Cash from financing activities | 4,737 | 11,003 | ||||||
Change in net cash and cash equivalents | 12,317 | 26,604 | ||||||
Net cash and cash equivalents - beginning of period | 353,537 | 270,317 | ||||||
Effect of exchange rate changes on cash and cash equivalents | 20,256 | 6,892 | ||||||
Net cash and cash equivalents - end of period | $ | 386,110 | $ | 303,813 |
December 31, 2016 | March 31, 2017 | ||||||
Cash and cash equivalents | $ | 270,317 | $ | 303,813 | |||
Trade receivables, net of allowance | 397,244 | 340,837 | |||||
Other taxes | 52,942 | 44,834 | |||||
Other current assets | 19,340 | 22,772 | |||||
Non-current financial assets | $ | 17,029 | $ | 19,857 | |||
Total | $ | 756,872 | $ | 732,113 |
December 31, 2016 | March 31, 2017 | ||||||||||||||||||||||||||
Gross value | % | Allowance | % | Gross value | % | Allowance | % | ||||||||||||||||||||
(in thousands) | (in thousands) | (in thousands) | (in thousands) | ||||||||||||||||||||||||
Not yet due | $ | 265,600 | 65.0 | % | $ | — | — | % | $ | 232,460 | 65.5 | % | $ | (735 | ) | 5.6 | % | ||||||||||
0 - 30 days | 92,163 | 22.5 | % | (49 | ) | 0.4 | % | 70,289 | 19.9 | % | (360 | ) | 2.7 | % | |||||||||||||
31 - 60 days | 19,747 | 4.8 | % | (182 | ) | 1.6 | % | 16,196 | 4.6 | % | (628 | ) | 4.7 | % | |||||||||||||
61 - 90 days | 6,055 | 1.5 | % | (191 | ) | 1.6 | % | 8,022 | 2.3 | % | (380 | ) | 2.9 | % | |||||||||||||
> 90 days | 25,277 | 6.2 | % | (11,176 | ) | 96.4 | % | 27,099 | 7.7 | % | (11,126 | ) | 84.2 | % | |||||||||||||
Total | $ | 408,842 | 100.0 | % | $ | (11,598 | ) | 100.0 | % | $ | 354,066 | 100.0 | % | $ | (13,229 | ) | 100.1 | % |
December 31, 2016 | |||||||
Carrying Value | Fair value | ||||||
(in thousands) | |||||||
Trade payables | $ | 365,788 | $ | 365,788 | |||
Other taxes | 44,831 | 44,831 | |||||
Employee-related payables | 55,874 | 55,874 | |||||
Other current liabilities | 30,221 | 30,221 | |||||
Financial liabilities | 85,580 | 85,580 | |||||
of which derivative financial instruments | 1,968 | 1,968 | |||||
Total | $ | 582,294 | $ | 582,294 |
March 31, 2017 | |||||||
Carrying Value | Fair value | ||||||
(in thousands) | |||||||
Trade payables | $ | 295,602 | $ | 295,602 | |||
Other taxes | 41,414 | 41,414 | |||||
Employee-related payables | 53,862 | 53,862 | |||||
Other current liabilities | 35,032 | 35,032 | |||||
Financial liabilities | 87,018 | 87,018 | |||||
of which derivative financial instruments | 4,186 | $ | 4,186 | ||||
Total | $ | 512,928 | $ | 512,928 |
Fair Value Measurement Using | |||||||||||||||
December 31, 2016 | Level 1 | Level 2 | Level 3 | ||||||||||||
(in thousands) | |||||||||||||||
Money market funds | $ | 31,688 | $ | 31,688 | $ | — | $ | — | |||||||
Interest-bearing bank deposits | 88,091 | — | 88,091 | — | |||||||||||
Cash and cash equivalents | 150,538 | 150,538 | — | — | |||||||||||
Total Cash and cash equivalents | $ | 270,317 | $ | 182,226 | $ | 88,091 | $ | — |
Fair Value Measurement Using | |||||||||||||||
March 31, 2017 | Level 1 | Level 2 | Level 3 | ||||||||||||
(in thousands) | |||||||||||||||
Money market funds | $ | — | $ | — | $ | — | $ | — | |||||||
Interest-bearing bank deposits | 87,377 | — | 87,377 | — | |||||||||||
Cash and cash equivalents | 216,436 | 216,436 | — | — | |||||||||||
Total Cash and cash equivalents | $ | 303,813 | $ | 216,436 | $ | 87,377 | $ | — |
December 31, 2016 | March 31, 2017 | ||||||
(in thousands) | |||||||
Trade accounts receivables | $ | 408,842 | $ | 354,066 | |||
(Less) Allowance for doubtful accounts | (11,598 | ) | (13,229 | ) | |||
Net book value at end of period | $ | 397,244 | $ | 340,837 |
2016 | 2017 | ||||||
(in thousands) | |||||||
Balance at January 1 | $ | (6,264 | ) | $ | (11,598 | ) | |
Allowance for doubtful accounts | (906 | ) | (3,686 | ) | |||
Reversal of provision | 366 | 2,142 | |||||
Currency translation adjustment | (147 | ) | (87 | ) | |||
Balance at March 31 | $ | (6,951 | ) | $ | (13,229 | ) |
December 31, 2016 | March 31, 2017 | ||||||
(in thousands) | |||||||
Prepayments to suppliers | $ | 2,439 | $ | 4,114 | |||
Other debtors | 3,263 | 2,816 | |||||
Prepaid expenses | 13,638 | 15,842 | |||||
Gross book value at end of period | 19,340 | 22,772 | |||||
Net book value at end of period | $ | 19,340 | $ | 22,772 |
December 31, 2016 | March 31, 2017 | ||||||||||
Weighted-Average Useful Lives (Years) | Amounts recognized as of Acquisition Date (in millions) | Weighted-Average Useful Lives (Years) | Amounts recognized as of Acquisition Date (in millions) | ||||||||
Technology | 3-5 years | 24.4 | 3 years | 15.3 | |||||||
Customer relationships | 5-9 years | $ | 60.0 | 9 years | $ | 77.7 | |||||
Total identifiable intangible assets acquired | $ | 84.4 | $ | 93.0 |
Software | Technology and customer relationships | Total | |||||||||
From April 1, to December 31, 2017 | $ | 4,436 | $ | 12,207 | $ | 16,643 | |||||
2018 | 5,246 | 16,122 | 21,368 | ||||||||
2019 | 3,091 | 14,148 | 17,239 | ||||||||
2020 | 1,278 | 8,628 | 9,906 | ||||||||
2021 | 389 | 8,628 | 9,017 | ||||||||
Thereafter | — | 33,789 | 33,789 | ||||||||
Total | $ | 14,440 | $ | 93,522 | $ | 107,962 |
Goodwill | |||
(in thousands) | |||
Balance at January 1, 2017 | 209,418 | ||
Additions to goodwill | 22,327 | ||
Currency translation adjustment | 393 | ||
Balance at March 31, 2017 | $ | 232,138 |
December 31, 2016 | March 31, 2017 | ||||||
(in thousands) | |||||||
Clients' prepayments | $ | 9,176 | $ | 12,816 | |||
Accounts payable relating to capital expenditures | 15,484 | 10,657 | |||||
Other creditors | $ | 2,440 | $ | 10,232 | |||
Deferred revenue | $ | 3,121 | $ | 1,327 | |||
Total | $ | 30,221 | $ | 35,032 |
As of January 1, 2017 | New borrowings | Repayments | Change in scope | Other (1) | Currency translation adjustment | As of March 31, 2017 | |||||||||||||||||||||
(in thousands) | |||||||||||||||||||||||||||
Borrowings | $ | 5,524 | $ | — | $ | (2,053 | ) | $ | — | $ | 76,546 | $ | 52 | $ | 80,069 | ||||||||||||
Other financial liabilities | 477 | — | (241 | ) | — | (96 | ) | 3 | 143 | ||||||||||||||||||
Derivative instruments | 1,968 | — | — | — | 2,181 | 37 | 4,186 | ||||||||||||||||||||
Current portion | 7,969 | — | (2,294 | ) | — | 78,631 | 92 | 84,398 | |||||||||||||||||||
Borrowings | 77,397 | — | — | — | (76,546 | ) | 1,096 | 1,947 | |||||||||||||||||||
Other financial liabilities | 214 | 360 | — | — | 99 | — | 673 | ||||||||||||||||||||
Non current portion | 77,611 | 360 | — | — | (76,447 | ) | 1,096 | 2,620 | |||||||||||||||||||
Borrowings | 82,921 | — | (2,053 | ) | — | — | 1,148 | 82,016 | |||||||||||||||||||
Other financial liabilities | 691 | 360 | (241 | ) | — | 3 | 3 | 816 | |||||||||||||||||||
Derivative instruments | 1,968 | — | — | — | 2,181 | 37 | 4,186 | ||||||||||||||||||||
Total | $ | 85,580 | $ | 360 | $ | (2,294 | ) | $ | — | $ | 2,184 | $ | 1,188 | $ | 87,018 |
OSA/BSPCE | RSU | BSA | Total | ||||||||
Balance at January 1, 2017 | 4,960,092 | 3,243,279 | 188,125 | 8,391,496 | |||||||
Granted | — | 231,460 | 10,825 | 242,285 | |||||||
Exercised | (671,993 | ) | — | (15,440 | ) | (687,433 | ) | ||||
Forfeited | (44,597 | ) | (76,377 | ) | — | (120,974 | ) | ||||
Expired | — | — | — | — | |||||||
Balance at March 31, 2017 | 4,243,502 | 3,398,362 | 183,510 | 7,825,374 |
OSA/BSPCE | RSU | BSA | ||||||||
Number outstanding | 4,243,502 | 3,398,362 | 183,510 | |||||||
Weighted-average exercise price | € | 24.67 | NA | € | 19.68 | |||||
Number exercisable | 2,326,206 | 10,460 | 112,435 | |||||||
Weighted-average exercise price | € | 18.69 | NA | € | 11.76 | |||||
Weighted-average remaining contractual life of options outstanding, in years | 7.20 | NA | 7.13 |
Three Months Ended | |||||||||||||||||||||||||||||||
March 31, 2016 | March 31, 2017 | ||||||||||||||||||||||||||||||
(in thousands) | |||||||||||||||||||||||||||||||
R&D | S&O | G&A | Total | R&D | S&O | G&A | Total | ||||||||||||||||||||||||
RSUs | $ | (1,256 | ) | $ | (1,668 | ) | $ | (1,101 | ) | $ | (4,025 | ) | $ | (3,472 | ) | $ | (6,260 | ) | $ | (2,728 | ) | $ | (12,460 | ) | |||||||
Share options / BSPCE | (1,146 | ) | (1,722 | ) | (1,388 | ) | (4,256 | ) | (444 | ) | (450 | ) | (1,229 | ) | (2,123 | ) | |||||||||||||||
Total share-based compensation | (2,402 | ) | (3,390 | ) | (2,489 | ) | (8,281 | ) | (3,916 | ) | (6,710 | ) | (3,957 | ) | (14,583 | ) | |||||||||||||||
BSAs | — | — | (89 | ) | (89 | ) | — | — | (357 | ) | (357 | ) | |||||||||||||||||||
Total equity awards compensation expense | $ | (2,402 | ) | $ | (3,390 | ) | $ | (2,578 | ) | $ | (8,370 | ) | $ | (3,916 | ) | $ | (6,710 | ) | $ | (4,314 | ) | $ | (14,940 | ) |
Three Months Ended | |||||||
March 31, 2016 | March 31, 2017 | ||||||
(in thousands) | |||||||
Financial income from cash equivalents | $ | 388 | $ | 248 | |||
Interest and fees | (476 | ) | (757 | ) | |||
Interest on debt | (270 | ) | (568 | ) | |||
Fees | (206 | ) | (189 | ) | |||
Foreign exchange gain (loss) | $ | (1,216 | ) | $ | (1,808 | ) | |
Other financial expense | (13 | ) | (16 | ) | |||
Total financial income (expense) | $ | (1,317 | ) | $ | (2,333 | ) |
Three Months Ended | |||||||
March 31, 2016 | March 31, 2017 | ||||||
(in thousands) | |||||||
Current income tax | $ | (9,082 | ) | $ | (11,071 | ) | |
France | (3,121 | ) | (4,572 | ) | |||
International | (5,961 | ) | (6,499 | ) | |||
Net change in deferred taxes | 1,138 | 6,870 | |||||
France | 1,216 | 601 | |||||
International | (78 | ) | 6,269 | ||||
Provision for income taxes | $ | (7,944 | ) | $ | (4,201 | ) |
Three Months Ended | |||||||
March 31, 2016 | March 31, 2017 | ||||||
(in thousands, except share and per share data) | |||||||
Net income attributable to shareholders of Criteo S.A. | $ | 17,131 | $ | 12,442 | |||
Weighted average number of shares outstanding | 62,610,013 | 64,189,194 | |||||
Basic earnings per share | $ | 0.27 | $ | 0.19 |
Three Months Ended | |||||||
March 31, 2016 | March 31, 2017 | ||||||
(in thousands, except share and per share data) | |||||||
Net income attributable to shareholders of Criteo S.A. | $ | 17,131 | $ | 12,442 | |||
Weighted average number of shares outstanding of Criteo S.A. | 62,610,013 | 64,189,194 | |||||
Dilutive effect of : | |||||||
Restricted share awards | — | 1,277,928 | |||||
Share options and BSPCE | 2,144,884 | 1,722,009 | |||||
Share warrants | 86,237 | 93,881 | |||||
Weighted average number of shares outstanding used to determine diluted earnings per share | 64,841,134 | 67,283,012 | |||||
Diluted earnings per share | $ | 0.26 | $ | 0.18 |
Three Months Ended | |||||
March 31, 2016 | March 31, 2017 | ||||
Restricted share awards | 1,038,691 | 229,730 | |||
Share options and BSPCE | — | 442,910 | |||
Share warrants | — | — | |||
Weighted average number of anti-dilutive securities excluded from diluted earnings per share | 1,038,691 | 672,640 |
Provision for employee-related litigation | Other provisions | Total | |||||||||
(in thousands) | |||||||||||
Balance at January 1, 2017 | $ | 485 | $ | 169 | $ | 654 | |||||
Charges | 12 | 516 | 528 | ||||||||
Provision used | (197 | ) | — | (197 | ) | ||||||
Provision released not used | (16 | ) | — | (16 | ) | ||||||
Currency translation adjustments | 6 | 5 | 11 | ||||||||
Balance at March 31, 2017 | $ | 290 | $ | 690 | $ | 980 | |||||
- of which current | 290 | 690 | 980 |
• | Americas (North and South America); |
• | EMEA (Europe, Middle-East and Africa); and |
• | Asia-Pacific. |
Americas | EMEA | Asia-Pacific | Total | ||||||||||||
For the three months ended: | (in thousands) | ||||||||||||||
March 31, 2016 | $ | 147,174 | $ | 159,405 | $ | 94,674 | $ | 401,253 | |||||||
March 31, 2017 | $ | 208,013 | $ | 189,092 | $ | 119,562 | $ | 516,667 |
Three Months Ended | ||||||||
March 31, 2016 | March 31, 2017 | |||||||
Americas | ||||||||
United States | $ | 126,913 | $ | 179,663 | ||||
EMEA | ||||||||
Germany | $ | 33,696 | $ | 42,614 | ||||
United Kingdom | $ | 28,509 | $ | 28,197 | ||||
Asia-Pacific | ||||||||
Japan | $ | 65,973 | $ | 85,310 |
Of which | Of which | ||||||||||||||||||||||||||
Holding | Americas | United States | EMEA | Asia-Pacific | Japan | Total | |||||||||||||||||||||
(in thousands) | |||||||||||||||||||||||||||
December 31, 2016 | $ | 55,052 | $ | 123,308 | $ | 42,474 | $ | 7,132 | $ | 26,033 | $ | 8,965 | $ | 211,525 | |||||||||||||
March 31, 2017 | $ | 58,670 | $ | 134,705 | $ | 133,969 | $ | 7,150 | $ | 22,852 | $ | 7,897 | $ | 223,377 |
Three Months Ended | ||||||||
March 31, 2016 | March 31, 2017 | |||||||
(in thousands, except share and per share data) (unaudited) | ||||||||
Revenue | $ | 401,253 | $ | 516,667 | ||||
Cost of revenue (2): | ||||||||
Traffic acquisition costs | (238,755 | ) | (306,693 | ) | ||||
Other cost of revenue | (18,338 | ) | (27,155 | ) | ||||
Gross profit | 144,160 | 182,819 | ||||||
Operating expenses | ||||||||
Research and development expenses (2) | (27,162 | ) | (39,521 | ) | ||||
Sales and operations expenses (2) | (64,473 | ) | (90,730 | ) | ||||
General and administrative expenses (2) | (24,737 | ) | (31,516 | ) | ||||
Total operating expenses | (116,372 | ) | (161,767 | ) | ||||
Income from operations | 27,788 | 21,052 | ||||||
Financial income (expense) | (1,317 | ) | (2,333 | ) | ||||
Income before taxes | 26,471 | 18,719 | ||||||
Provision for income taxes | (7,944 | ) | (4,201 | ) | ||||
Net income | $ | 18,527 | $ | 14,518 | ||||
Net income available to shareholders of Criteo S.A. (1) | $ | 17,131 | $ | 12,442 | ||||
Net income available to shareholders of Criteo S.A. per share: | ||||||||
Basic | $ | 0.27 | $ | 0.19 | ||||
Diluted | $ | 0.26 | $ | 0.18 | ||||
Weighted average shares outstanding used in computing per share amounts: | ||||||||
Basic | 62,610,013 | 64,189,194 | ||||||
Diluted | 64,841,134 | 67,283,012 |
Three Months Ended | ||||||||
March 31, 2016 | March 31, 2017 | |||||||
(in thousands) (unaudited) | ||||||||
Equity awards compensation expense | ||||||||
Research and development expenses | $ | 2,402 | $ | 3,916 | ||||
Sales and operations expenses | 3,390 | 6,710 | ||||||
General and administrative expenses | 2,578 | 4,314 | ||||||
Total equity awards compensation expense | $ | 8,370 | $ | 14,940 | ||||
Pension service costs | ||||||||
Research and development expenses | 52 | 146 | ||||||
Sales and operations expenses | 34 | 59 | ||||||
General and administrative expenses | 43 | 85 | ||||||
Total pension service costs (a) | $ | 129 | $ | 290 | ||||
Depreciation and amortization expense | ||||||||
Cost of revenue | 8,220 | 11,091 | ||||||
Research and development expenses (b) | 2,007 | 2,944 | ||||||
Sales and operations expenses (c) | 1,771 | 4,961 | ||||||
General and administrative expenses | 518 | 1,171 | ||||||
Total depreciation and amortization expense | $ | 12,516 | $ | 20,167 | ||||
Acquisition-related costs | ||||||||
General and administrative expenses | — | 6 | ||||||
Total acquisition-related costs | $ | — | $ | 6 | ||||
Acquisition-related deferred price consideration | ||||||||
Research and development expenses | 40 | — | ||||||
Total acquisition-related deferred price consideration | $ | 40 | $ | — |
December 31, 2016 | March 31, 2017 | ||||||
(in thousands) (unaudited) | |||||||
Cash and cash equivalents | $ | 270,317 | $ | 303,813 | |||
Total assets | 1,211,186 | 1,237,389 | |||||
Trade receivables, net of allowances for doubtful accounts | 397,244 | 340,837 | |||||
Total financial liabilities | 85,580 | 87,018 | |||||
Total liabilities | 601,309 | 565,750 | |||||
Total equity | $ | 609,877 | $ | 671,639 |
Three Months Ended | |||||||
March 31, 2016 | March 31, 2017 | ||||||
(in thousands) (unaudited) | |||||||
Number of clients | 10,962 | 15,423 | |||||
Revenue ex-TAC (3) | $ | 162,498 | $ | 209,974 | |||
Adjusted Net Income (4) | $ | 28,086 | $ | 30,821 | |||
Adjusted EBITDA (5) | $ | 48,843 | $ | 56,454 |
Three Months Ended | |||||||
March 31, 2016 | March 31, 2017 | ||||||
(in thousands) (unaudited) | |||||||
Revenue | $ | 401,253 | $ | 516,667 | |||
Adjustment: | |||||||
Traffic acquisition costs | (238,755 | ) | (306,693 | ) | |||
Revenue ex-TAC | $ | 162,498 | $ | 209,974 |
Three Months Ended | |||||||
March 31, 2016 | March 31, 2017 | ||||||
(in thousands) (unaudited) | |||||||
Net income | $ | 18,527 | $ | 14,518 | |||
Adjustments: | |||||||
Equity awards compensation expense | 8,370 | 14,940 | |||||
Amortization of acquisition-related intangible assets | 1,377 | 4,674 | |||||
Acquisition-related costs | — | 6 | |||||
Acquisition-related deferred price consideration | 40 | — | |||||
Tax impact of the above adjustments | (228 | ) | (3,317 | ) | |||
Adjusted Net Income | $ | 28,086 | $ | 30,821 |
Three Months Ended | |||||||
March 31, 2016 | March 31, 2017 | ||||||
(in thousands) | |||||||
Net income | $ | 18,527 | $ | 14,518 | |||
Adjustments: | |||||||
Financial expense (income) | 1,317 | 2,333 | |||||
Provision for income taxes | 7,944 | 4,201 | |||||
Equity awards compensation expense | 8,370 | 14,940 | |||||
Pension service costs | 129 | 290 | |||||
Depreciation and amortization expense | 12,516 | 20,167 | |||||
Acquisition-related costs | — | 6 | |||||
Acquisition-related deferred price consideration | 40 | — | |||||
Total net adjustments | 30,316 | 41,936 | |||||
Adjusted EBITDA | $ | 48,843 | $ | 56,454 |
Three Months Ended | ||||||||||
March 31, 2016 | March 31, 2017 | 2016 vs 2017 | ||||||||
(in thousands) | ||||||||||
Revenue as reported | $ | 401,253 | $ | 516,667 | 29 | % | ||||
Conversion impact U.S dollar/other currencies | 3,732 | |||||||||
Revenue at constant currency (1) | 401,253 | 520,399 | 30 | % | ||||||
Americas | ||||||||||
Revenue as reported | 147,174 | 208,013 | 41 | % | ||||||
Conversion impact U.S dollar/other currencies | (3,494 | ) | ||||||||
Revenue at constant currency (1) | 147,174 | 204,519 | 39 | % | ||||||
EMEA | ||||||||||
Revenue as reported | 159,405 | 189,092 | 19 | % | ||||||
Conversion impact U.S dollar/other currencies | 9,063 | |||||||||
Revenue at constant currency (1) | 159,405 | 198,155 | 24 | % | ||||||
Asia-Pacific | ||||||||||
Revenue as reported | 94,674 | 119,562 | 26 | % | ||||||
Conversion impact U.S dollar/other currencies | (1,837 | ) | ||||||||
Revenue at constant currency(1) | $ | 94,674 | $ | 117,725 | 24 | % |
Three Months Ended | % change | ||||||||
March 31, 2016 | March 31, 2017 | 2016 vs 2017 | |||||||
(in thousands, except percentages) | |||||||||
Traffic acquisition costs | $ | (238,755 | ) | $ | (306,693 | ) | 28% | ||
Other cost of revenue | $ | (18,338 | ) | $ | (27,155 | ) | 48% | ||
% of revenue | (64 | )% | (65 | )% | |||||
Gross profit % | 36 | % | 35 | % |
Three Months Ended | % change | ||||||||
March 31, 2016 | March 31, 2017 | 2016 vs 2017 | |||||||
(in thousands, except percentages) | |||||||||
Research and development expenses | $ | (27,162 | ) | $ | (39,521 | ) | 46% | ||
% of revenue | (7 | )% | (8 | )% |
Three Months Ended | % change | ||||||||
March 31, 2016 | March 31, 2017 | 2016 vs 2017 | |||||||
(in thousands, except percentages) | |||||||||
Sales and operations expenses | $ | (64,473 | ) | $ | (90,730 | ) | 41% | ||
% of revenue | (16 | )% | (18 | )% |
Three Months Ended | % change | ||||||||
March 31, 2016 | March 31, 2017 | 2016 vs 2017 | |||||||
(in thousands, except percentages) | |||||||||
General and administrative expenses | $ | (24,737 | ) | $ | (31,516 | ) | 27% | ||
% of revenue | (6 | )% | (6 | )% |
Three Months Ended | % change | ||||||||
March 31, 2016 | March 31, 2017 | 2016 vs 2017 | |||||||
(in thousands, except percentages) | |||||||||
Financial income (expense) | $ | (1,317 | ) | $ | (2,333 | ) | 77% | ||
% of revenue | — | % | — | % |
Three Months Ended | % change | ||||||||
March 31, 2016 | March 31, 2017 | 2016 vs 2017 | |||||||
(in thousands, except percentages) | |||||||||
Provision for income taxes | $ | (7,944 | ) | $ | (4,201 | ) | (47)% | ||
% of revenue | (2 | )% | (1 | )% | |||||
Effective tax rate | 30 | % | 22 | % |
Three Months Ended | % change | ||||||||
March 31, 2016 | March 31, 2017 | 2016 vs 2017 | |||||||
(in thousands, except percentages) | |||||||||
Net income | $ | 18,527 | $ | 14,518 | (22)% | ||||
% of revenue | 5 | % | 3 | % |
Three Months Ended | ||||||||||||
Region | March 31, 2016 | March 31, 2017 | Year over Year Change | |||||||||
Revenue: | (amounts in thousands, except percentages) | |||||||||||
Americas | $ | 147,174 | $ | 208,013 | 41 | % | ||||||
EMEA | 159,405 | 189,092 | 19 | % | ||||||||
Asia-Pacific | 94,674 | 119,562 | 26 | % | ||||||||
Total | 401,253 | 516,667 | 29 | % | ||||||||
Traffic acquisition costs: | ||||||||||||
Americas | (90,929 | ) | (128,867 | ) | 42 | % | ||||||
EMEA | (91,185 | ) | (107,583 | ) | 18 | % | ||||||
Asia-Pacific | (56,641 | ) | (70,243 | ) | 24 | % | ||||||
Total | (238,755 | ) | (306,693 | ) | 28 | % | ||||||
Revenue ex-TAC (1): | ||||||||||||
Americas | 56,245 | 79,146 | 41 | % | ||||||||
EMEA | 68,220 | 81,509 | 19 | % | ||||||||
Asia-Pacific | 38,033 | 49,319 | 30 | % | ||||||||
Total | $ | 162,498 | $ | 209,974 | 29 | % |
Three Months Ended | |||||||||||
March 31, 2016 | March 31, 2017 | YoY Change | |||||||||
(amounts in thousands, except percentages) | |||||||||||
Revenue as reported | $ | 401,253 | $ | 516,667 | 29 | % | |||||
Conversion impact U.S. dollar/other currencies | 3,732 | ||||||||||
Revenue at constant currency | $ | 401,253 | $ | 520,399 | 30 | % | |||||
Traffic acquisition costs as reported | $ | (238,755 | ) | $ | (306,693 | ) | 28 | % | |||
Conversion impact U.S. dollar/other currencies | $ | (2,231 | ) | ||||||||
Traffic Acquisition Costs at constant currency | $ | (238,755 | ) | $ | (308,924 | ) | 29 | % | |||
Revenue ex-TAC as reported | $ | 162,498 | $ | 209,974 | 29 | % | |||||
Conversion impact U.S. dollar/other currencies | $ | 1,501 | |||||||||
Revenue ex-TAC at constant currency | $ | 162,498 | $ | 211,475 | 30 | % | |||||
Revenue ex-TAC/Revenue as reported | 40 | % | 41 | % | |||||||
Other cost of revenue as reported | $ | (18,338 | ) | $ | (27,155 | ) | 48 | % | |||
Conversion impact U.S. dollar/other currencies | (216 | ) | |||||||||
Other cost of revenue at constant currency | $ | (18,338 | ) | $ | (27,371 | ) | 49 | % | |||
Adjusted EBITDA as reported | $ | 48,843 | $ | 56,454 | 16 | % | |||||
Conversion impact U.S. dollar/other currencies | 1,168 | ||||||||||
Adjusted EBITDA at constant currency | $ | 48,843 | $ | 57,622 | 18 | % |
Three Months Ended | |||||||
March 31, 2016 | March 31, 2017 | ||||||
(in thousands) | |||||||
Cash from operating activities | $ | 18,907 | $ | 44,238 | |||
Cash used in investing activities | $ | (11,327 | ) | $ | (28,637 | ) | |
Cash from financing activities | $ | 4,737 | $ | 11,003 |
Three Months Ended | |||||||||||||||
March 31, 2016 | March 31, 2017 | ||||||||||||||
(in thousands) | |||||||||||||||
GBP/USD | +10% | -10% | +10% | -10% | |||||||||||
Net income impact | $ | (82 | ) | $ | 82 | $ | 9 | $ | (9 | ) |
Three Months Ended | |||||||||||||||
March 31, 2016 | March 31, 2017 | ||||||||||||||
(in thousands) | |||||||||||||||
BRL/USD | +10% | -10% | +10% | -10% | |||||||||||
Net income impact | $ | 154 | $ | (154 | ) | $ | 54 | $ | (54 | ) |
Three Months Ended | |||||||||||||||
March 31, 2016 | March 31, 2017 | ||||||||||||||
(in thousands) | |||||||||||||||
JPY/USD | +10% | -10% | +10% | -10% | |||||||||||
Net income impact | $ | 271 | $ | (271 | ) | $ | 403 | $ | (403 | ) |
Three Months Ended | |||||||||||||||
March 31, 2016 | March 31, 2017 | ||||||||||||||
(in thousands) | |||||||||||||||
EUR/USD | +10% | -10% | +10% | -10% | |||||||||||
Net income impact | $ | 1,684 | $ | (1,684 | ) | $ | 2,401 | $ | (2,401 | ) |
Incorporated by Reference | ||||||||||
Exhibit | Description | Schedule/ Form | File Number | Exhibit | File Date | |||||
4.1 | Amendment and Restatement Agreement, dated as of March 29, 2017, by and among Criteo S.A., Criteo Finance S.A.S. and Criteo Corp., as borrowers, BNP Paribas, Crédit Lyonnais (LCL), HSBC France, Natixis and Société Générale Corporate & Investment Banking as arrangers, Natixis as coordinator and documentation agent, Crédit Lyonnais (LCL) as agent, and the financial institutions listed therein as lenders. | 8-K | 001-36153 | 4.1 | March 30, 2017 | |||||
10.1†# | Employment Agreement between the registrant and Dan Teodosiu, dated November 20, 2012 (English translation) | |||||||||
10.2†# | Employment Offer Letter between the registrant and Mary (Mollie) Spilman, dated July 30, 2014 | |||||||||
31.1# | Certificate of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |||||||||
31.2# | Certificate of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |||||||||
32.1* | Certificate of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |||||||||
101.INS | XBRL Instance Document | |||||||||
101.SCH | XBRL Taxonomy Extension Schema Document | |||||||||
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | |||||||||
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | |||||||||
101.LAB | XBRL Taxonomy Extension Labels Linkbase Document | |||||||||
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document |
CRITEO S.A. | ||
(Registrant) | ||
By: | /s/ Benoit Fouilland | |
Date: May 10, 2017 | Name: | Benoit Fouilland |
Title: | Chief Financial Officer | |
(Principal financial officer and duly authorized signatory) |
(i) | from entering into the service, in any capacity whatsoever (employee, company representative, independent consultant, etc.): |
• | of a company whose principal activity is developing and/or selling products in competition with those of the Company, namely a behavioral retargeting or targeting solution, |
• | of the department in charge of targeting or retargeting solutions within a company whose ancillary activity is selling and/or developing these solutions. |
(ii) | from participating, in any form whatsoever, directly or indirectly, in the activity of a company of this kind and within a department specializing in this activity. |
• | denigration of the Company’s product/services or policies and more generally any denigration harming the Company’s reputation, |
• | voluntary creating confusion between the Company and any new employer (name or acronym that are nearly identical, use of distinctive signs, etc.) |
• | any act that may harm the Company’s organization, such as poaching the Company’s staff, hijacking of clients, etc. |
• | The collective and compulsory “disability, invalidity, death” scheme, |
• | The collective and compulsory “reimbursement of medical costs” scheme. |
Dan Teodosiu | On behalf of the Company |
“Read and approved” | Antoine Mingalon |
/s/ Dan Teodosiu | /s/ Antoine Mingalon |
(a) | During your employment with the Company, you will devote all of your business time, best efforts and business judgment, skill and knowledge to the advancement of the Company's interests and to the discharge of your duties and responsibilities under this Agreement. You shall abide by all legal, professional, ethical and Company requirements, rules, regulations, policies and practices applicable to your work. The Company expects you to abide by all such restrictions or obligations and to avoid any act that could pose a conflict as a result of confidential, proprietary or trade secret information obtained by you prior to your employment by the Company. By agreeing to become employed by the Company, you represent that none of these restrictions or obligations is inconsistent with your serving as an employee of the Company. |
(b) | During the term of your employment with the Company, you will not, without the Company's written consent, (1) form or attempt to form a business in competition with the Company; (2) render or perform services of a business, professional or commercial nature other than to or for the Company, either alone or as an employee, consultant, director, officer or partner of another business entity, whether or not for compensation, and whether or not such activity, occupation or endeavor is similar to, competitive with or adverse to the business or welfare of the Company; or (3) invest in or become a shareholder of or consultant to another corporation or other entity, provided that your investment solely as a shareholder in another corporation shall not be prohibited hereby so long as such investment is not in excess of 1% of any class of shares that are traded on a national securities exchange. |
Regards, | ||
CRITEO CORP | ||
Effective Date: 8/6/14 | By: | /s/ Dipti Salopek |
Candidate Name: | /s/ Mollie Spilman | Date: | 8/6/14 |
Mollie SPILMAN |
/s/ Eric Eichmann |
Eric Eichmann |
Chief Executive Officer (Principal Executive Officer) |
/s/ Benoit Fouilland |
Benoit Fouilland |
Chief Financial Officer (Principal Financial and Accounting Officer) |
1. | The Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2017, to which this Certification is attached as Exhibit 32.1 (the “Quarterly Report”), fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act, and |
2. | The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ Eric Eichmann | /s/ Benoit Fouilland | |
Eric Eichmann | Benoit Fouilland | |
Chief Executive Officer | Chief Financial Officer |
Document and Entity Information - shares |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Apr. 30, 2017 |
|
Document and Entity Information [Abstract] | ||
Entity Registrant Name | Criteo S.A. | |
Entity Central Index Key | 0001576427 | |
Current Fiscal Year End Date | --12-31 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Document Fiscal Year Focus | 2017 | |
Document Fiscal Period Focus | Q1 | |
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Mar. 31, 2017 | |
Entity Common Stock, Shares Outstanding | 64,754,393 |
CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (UNAUDITED) (PARENTHETICAL) - € / shares |
Mar. 31, 2017 |
Dec. 31, 2016 |
---|---|---|
Statement of Financial Position [Abstract] | ||
Common shares, par value (in Euro per share) | € 0.025 | € 0.025 |
Common shares authorized (in shares) | 64,665,637 | 63,978,204 |
Common shares issued (in shares) | 64,665,637 | 63,978,204 |
Common shares outstanding (in shares) | 64,665,637 | 63,978,204 |
Summary of Significant Accounting Policies |
3 Months Ended |
---|---|
Mar. 31, 2017 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Criteo S.A. is a global technology company specialized in digital performance marketing. We strive to deliver post-click sales to our advertiser clients at scale and according to the client's targeted return on investment. In these notes, Criteo S.A. is referred to as the "Parent" company and together with its subsidiaries, collectively, as "Criteo," the "Company," the "Group," or "we". The Company uses its proprietary predictive software algorithms coupled with its deep insights into expressed consumer intent and purchasing habits to price and deliver highly relevant and personalized performance advertisements to consumers in real time. Summary of Significant Accounting Policies Basis of Presentation The unaudited condensed consolidated financial statements included herein have been prepared by Criteo S.A. pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. However, the Company believes that the disclosures are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company's Annual Report filed on Form 10-K for the year ended December 31, 2016, filed with the SEC on March 1, 2017. The unaudited condensed consolidated financial statements included herein reflect all adjustments (consisting of normal, recurring adjustments) which are, in the opinion of management, necessary to state fairly the results for the interim periods presented. The results of operations for the interim periods presented are not necessarily indicative of the operating results to be expected for any subsequent interim period or for the fiscal year. Conformity with U.S. GAAP requires the use of estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses in the condensed consolidated financial statements and accompanying notes. We base our estimates and judgments on historical information and on various other assumptions that we believe are reasonable under the circumstances. Our actual results may differ from these estimates. U.S. GAAP requires us to make estimates and judgments in several areas, including, but not limited to: (1) the recognition of revenue and particularly the determination as to whether revenue should be reported on a gross or a net basis; (2) the evaluation of our trade receivables and the recognition of a valuation allowance for doubtful accounts; (3) the recognition and measurement of goodwill and intangible assets and particularly costs capitalized in relation to our customized internal-use software; (4) the measurement of share-based compensation and (5) the tax provision determination and particularly the estimate of our annual effective tax rate. There have been no changes to our significant accounting policies described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016 that have had a material impact on our unaudited condensed consolidated financial statements and related notes. Accounting Pronouncements adopted in 2017 From January 1, 2017, we adopted ASU 2016-09, Compensation-Stock Compensation (Topic 718): Improvement to Employee Share-based Payment Accounting issued by the Financial Accounting Standards Board (FASB), which among other items, simplifies certain aspects of the accounting for share-based payment transactions to employees. The new standard particularly requires excess tax benefits and tax deficiencies to be recorded in the statements of income as a component of the provision for income taxes when stock awards vest or are settled. The effective date is January 1, 2017. Upon adoption, a cumulative effect of $10.0 million of this change has been recognized through retained earnings. The adoption of the standard also resulted in a current year tax expense of $0.8 million which previously would have been recognized in the current period in additional paid-in capital. Accounting Pronouncements not yet adopted In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805) ("ASU 2017-01") the purpose of which is to change the definition of a business to assist entities in evaluating when a set of transferred assets and activities is a business. This update will be effective for annual periods beginning after December 15, 2017, including interim periods within those periods. The adoption of ASU 2017-01 is not expected to have a material impact on our financial position or results of operations. In January 2017, the FASB issued ASU 2017-04 Goodwill and Other (Topic 350). ASU 2017-04 simplifies the subsequent measurement of goodwill and reduces the cost and complexity of evaluating goodwill for impairment. It eliminates the need for entities to calculate the implied fair value of goodwill by assigning the fair value of a reporting unit to all of its assets and liabilities as if that reporting unit had been acquired in a business combination. Under this amendment, an entity will perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge is recognized for the amount by which the carrying value exceeds the reporting unit's fair value. This update will be effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. The adoption of ASU 2017-04 is not expected to have a material impact on our financial position or results of operations. In March 2017, FASB issued ASU 2017-07 Compensation-Retirements Benefits (Topic 715). ASU 2017-07 requires that an employer disaggregate the service cost component from the other components of net benefit cost. The amendments also provide explicit guidance on how to present the service cost component and the other components of net benefit cost in the income statement and allow only the service cost component of net benefit cost to be eligible for capitalization. The amendments in ASU 2017-07 improve the consistency, transparency, and usefulness of financial information to users that have communicated that the service cost component generally is analyzed differently from the other components of net benefit cost. This update will be effective for annual periods beginning after December 15, 2017, including interim periods within those annual periods. The amendments in ASU 2017-07 should be applied retrospectively for the presentation of the service cost component and the other components of net periodic pension cost and net periodic post-retirement benefit cost in the income statement and prospectively, on and after the effective date, for the capitalization of the service cost component of net periodic pension cost and net periodic post-retirement benefit in assets. We intend to adopt the standard on the effective date of January 1, 2018. The adoption of ASU 2017-07 is not expected to have a material impact on our financial position or results of operations. |
Significant Events and Transactions of the Period |
3 Months Ended |
---|---|
Mar. 31, 2017 | |
Significant Events and Transactions of the Period Disclosure [Abstract] | |
Significant Events and Transactions of the Period | Significant Events and Transactions of the Period Amendment on Group Revolving Credit Facility agreement In September 2015, Criteo S.A. entered into a Multicurrency Revolving Facility Agreement for general purposes of the Group including the funding of business combinations. On March 29, 2017, this agreement was amended by, among other things, increasing the amount of facility from €250.0 million to €350.0 million and extending the term of the contract from 2020 to 2022. |
Financial Instruments |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Instruments | Financial Instruments Credit Risk The maximum exposure to credit risk at the end of each reported period is represented by the carrying amount of financial assets, and summarized in the following table:
As of December 31, 2016 and March 31, 2017, no customer accounted for 10% or more of trade receivables. We perform ongoing credit evaluations of our customers and do not require collateral. We maintain an allowance for estimated credit losses. During the twelve-month period ended December 31, 2016 and the three-month period ended March 31, 2017, our net change in allowance for doubtful accounts was $5.4 million and $1.5 million, respectively. For our financial assets, the fair value approximates the carrying amount, given the nature of the financial assets and the maturity of the expected cash flows. Fair Value Measurements We measure the fair value of our cash equivalents, which include money market funds and interest bearing deposits, as level 1 and level 2 measurements because they are valued using quoted market prices and observable market data, respectively. Financial assets or liabilities include derivative financial instruments used to manage our exposure to the risk of exchange rate fluctuations. These instruments are considered level 2 financial instruments as they are measured using valuation techniques based on observable market data. Trade Receivables Credit risk is defined as an unexpected loss in cash and earnings if the client is unable to pay its obligations in due time. We perform internal ongoing credit risk evaluations of our clients. When a possible risk exposure is identified, we require prepayments. For each period presented, the aging of trade receivables and allowances for potential losses is as follows:
Financial Liabilities
Cash and Cash equivalents
The short-term investments included investments in money market funds and interest–bearing bank deposits which met ASC 230—Statement of Cash flows criteria: short-term, highly liquid investments, for which the risks of changes in value are considered to be insignificant. |
Trade Receivables |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Receivables [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trade Receivables | Trade Receivables The following table shows the breakdown in trade receivables net book value for the presented periods:
Changes in allowance for doubtful accounts are summarized below:
The change in allowance for doubtful accounts for the first quarter of 2017 related mainly to increased business with categories of clients associated with a higher credit risk. |
Other Current Assets |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Current Assets | Other Current Assets The following table shows the breakdown in other current assets net book value for the presented periods:
Prepaid expenses mainly consist of office rentals. |
Intangible Assets |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Intangible Assets | Intangible assets The main changes in intangible assets since December 31, 2016 relate to purchase accounting adjustments to technology and customer relationships regarding HookLogic, which were identified as intangible assets further to the preliminary purchase price allocation. A change in this preliminary valuation may also impact the income tax related accounts. The amounts shown below may change in the near term as management continues to assess the fair value of acquired assets and liabilities within the twelve-month purchase price allocation period.
In addition, no triggering events have occurred which would indicate impairment in the balance of intangible assets. The estimated amortization expense related to intangible assets for the next five years and thereafter is as follows:
|
Goodwill |
3 Months Ended | ||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||
Goodwill | Goodwill
The main changes in goodwill since December 31, 2016 relate to purchase accounting adjustments to intangible assets regarding HookLogic, further to the preliminary purchase price allocation (note 6). In addition, no triggering events have occurred which would indicate impairment in the balance of goodwill. |
Other Current Liabilities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Liabilities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Current Liabilities | Other Current Liabilities Other current liabilities are presented in the following table:
|
Financial Liabilities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Liabilities | Financial Liabilities The changes in current and non-current financial liabilities during the period ended March 31, 2016 are illustrated in the following schedules:
(1) Includes reclassification from non-current to current portion based on maturity of the financial liabilities. Borrowings are financial liabilities at amortized cost and are measured using level 2 fair value measurements. We are party to several loan agreements and revolving credit facilities, or RCF, with third-party financial institutions. The only changes from what was disclosed in Note 14 to the consolidated financial statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2016 are the amendment to the revolving credit facility entered into in September 2015, which, among other things, increased the facility amount from €250.0 million to €350.0 million and the amendment of the HSBC Chinese RCF which increased the facility amount from RMB 40.0 million to RMB 50.0 million |
Share-Based Compensatoin |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-Based Compensation | Share-Based Compensation The board of directors has been authorized by the general meeting of the shareholders to grant employee warrants (Bons de Souscription de Parts de Créateur d’Entreprise or "BSPCEs"), share options (Options de Souscription d'Actions or "OSAs"), free shares/restricted share units ("RSUs") and non-employee warrants (Bons de Souscription d'Actions or "BSAs"). During the first quarter of 2017, there was one grant of RSUs under the Employee Share Option Plan 9 and one grant of BSAs under the Plan F, as defined in Note 19 to our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2016. On March 1, 2017, 231,460 RSUs were granted to Criteo employees subject to continued employment and 10,825 BSAs were granted to a board member subject to continued engagement on the board of directors. There have been no changes in the vesting and method of valuation of the BSPCEs, OSAs, RSUs, or BSAs from what was disclosed in Note 19 to the consolidated financial statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2016, filed with the SEC on March 1, 2017. Change in Number of BSPCE/OSA/RSU/BSA
Breakdown of the Closing Balance
Reconciliation with the Consolidated Statements of Income
|
Financial Income and Expenses |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Income and Expenses [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Income and Expenses | Financial Income and Expenses The condensed consolidated statements of income line item “Financial income (expense)” can be broken down as follows:
The $2.3 million financial (expense) is driven by the interest accrued as a result of drawing on the revolving credit facility entered into in September 2015 and the hedging cost related to an intra-group position between Criteo S.A. and its U.S. subsidiary, both in the context of the funding of HookLogic acquisition in November 2016. The $1.3 million financial expense for the three months ended March 31, 2016 was mainly a result of the weakening of the Brazilian Real which resulted in losses on intra-group positions denominated in this currency. At the end of March 2017, the main positions bearing a foreign currency risk are centralized at the Parent company level and hedged using foreign currency swaps and forward purchases or sales of foreign currencies. |
Income Taxes |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Taxes | Income Taxes Breakdown of Income Taxes The condensed consolidated statements of income line item “Provision for income taxes” can be broken down as follows:
Our tax provision for interim periods is determined using an estimate of our annual effective tax rate (“AETR”), adjusted for discrete items arising in that quarter. To calculate our estimated AETR, we estimate our income before taxes and the related tax expense or benefit for the full fiscal year (total of expected current and deferred tax provisions), excluding the effect of significant unusual or infrequently occurring items or comprehensive income items not recognized in the statement of income. Each quarter, we update our estimate of the annual effective tax rate, and if our estimated annual tax rate changes, we make a cumulative adjustment in that quarter. Our quarterly tax provision, and our quarterly estimate of our annual effective tax rate, are subject to significant volatility due to several factors including our ability to accurately predict our income (loss) before provision for income taxes in multiple jurisdictions and the changes in foreign exchange rates. Our effective tax rate in the future will depend on the portion of our profits earned within and outside of France. For the three months ended March 31, 2016 and 2017, we utilized an annual estimated tax rate of 30% and 29% respectively to calculate the provision for income taxes. The effective tax rate was 30% and 22% for the first quarter 2016 and 2017, respectively. The effective tax rate for three months ended March 31, 2017 decreased compared to the same period in 2016, primarily due to the tax impact of discrete items such as share-based compensation in the United States. Current tax assets and liabilities The total amount of current tax assets consists mainly of prepayments of income taxes by Criteo do Brasil LTDA and Criteo B.V. The current tax liabilities refers mainly to the net corporate tax payables of Criteo S.A., Criteo Srl, and Criteo KK. |
Earnings Per Share |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share | Earnings Per Share Basic Earnings Per Share We calculate basic earnings per share by dividing the net income for the period attributable to shareholders of the Parent by the weighted average number of shares outstanding.
Diluted Earnings Per Share We calculate diluted earnings per share by dividing the net income attributable to shareholders of the Parent by the weighted average number of shares outstanding plus any potentially dilutive shares not yet issued from share-based compensation plans (see Note 10). There were no other potentially dilutive instruments outstanding as of March 31, 2016 and 2017. Consequently all potential dilutive effects from shares are considered. For each period presented, a contract to issue a certain number of shares (i.e. share option, non-employee warrant ("BSA"), restricted share unit ("RSU") or non-employee warrant ("BSPCE") is assessed as potentially dilutive if it is “in the money” (i.e., the exercise or settlement price is lower than the average market price).
The weighted average number of securities that were anti-dilutive for diluted EPS for the periods presented but which could potentially dilute EPS in the future are as follows:
|
Commitments and contingencies |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and contingencies | Commitments and contingencies Commitments Leases We are party to various operating lease agreements mainly related to our offices as well as hosting services. Certain of these arrangements have free rent periods or escalating rent payment provisions, and we recognize rent expense under such arrangements on a straight-line basis. Operating lease expenses relating to our offices totaled $7.4 million and $8.8 million for the three-month period ended March 31, 2016 and 2017, respectively. Operating lease expenses relating to hosting costs totaled $9.3 million and $13.9 million for the three-month period ended March 31, 2016 and 2017, respectively. Revolving Credit Facilities, Credit Line Facilities and Bank Overdrafts As mentioned in Note 9, we are party to two RCFs including one with HSBC for which we can draw up to RMB 50.0 million ($7.3 million) and one with a syndicate of banks which allow us to draw up to €350.0 million ($374.2 million), further to the amendment signed in March 2017 increasing the facility amount from €250.0 million to €350.0 million and extending the term of the contract from 2020 to 2022. As of March 31, 2017, RMB 25.0 million ($3.6 million), and $75.0 million, respectively, had been drawn on the RCFs. All of these credit facilities are unsecured and contain customary events of default but do not contain any affirmative, financial or negative covenants, with the exception of the €350.0 million ($374.2 million) RCF which contains covenants, including compliance with a total net debt to adjusted EBITDA ratio and restrictions on incurring additional indebtedness. At March 31, 2017, we were in compliance with the required leverage ratio. Contingencies Changes in provisions during the presented periods are summarized below:
The amount of the provisions represent management’s best estimate of the future outflow. As of March 31, 2017, provisions are mainly in relation to employee-related litigations and business and operating risks. |
Breakdown of Revenue and Non-Current Assets by Geographical Areas |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Breakdown of Revenue and Non-Current Assets by Geographical Areas | Breakdown of Revenue and Non-Current Assets by Geographical Areas The Company operates in the following three geographical markets:
The following tables disclose our consolidated revenue for each geographical area for each of the reported periods. Revenue by geographical area is based on the location of advertisers’ campaigns.
Revenue generated in France amounted to $32.5 million and $37.5 million for the three months ended March 31, 2016 and 2017, respectively. Revenue generated in other significant countries where we operate is presented in the following table:
Other Information For each reported period, non-current assets (corresponding to the net book value of tangible and intangible assets) are presented in the table below. The geographical information results from the locations of legal entities.
|
Related Parties |
3 Months Ended |
---|---|
Mar. 31, 2017 | |
Related Party Transactions [Abstract] | |
Related Parties | Related Parties There were no significant related-party transactions during the period nor any change in the nature of the transactions as described in Note 24 to the consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2016. |
Subsequent Events |
3 Months Ended |
---|---|
Mar. 31, 2017 | |
Subsequent Events [Abstract] | |
Subsequent Events | Subsequent Events The Company evaluated all other subsequent events that occurred after March 31, 2017 through the date of issuance of the unaudited condensed consolidated financial statements. On April 29, 2017, the Company repaid the outstanding balance of the financial liability related to the RCF contracted in September 2015 ($75 million).There are no other significant events that require adjustments or disclosure. |
Summary of Significant Accounting Policies (Policies) |
3 Months Ended |
---|---|
Mar. 31, 2017 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The unaudited condensed consolidated financial statements included herein have been prepared by Criteo S.A. pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. However, the Company believes that the disclosures are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company's Annual Report filed on Form 10-K for the year ended December 31, 2016, filed with the SEC on March 1, 2017. The unaudited condensed consolidated financial statements included herein reflect all adjustments (consisting of normal, recurring adjustments) which are, in the opinion of management, necessary to state fairly the results for the interim periods presented. The results of operations for the interim periods presented are not necessarily indicative of the operating results to be expected for any subsequent interim period or for the fiscal year. |
Use of Estimates | Conformity with U.S. GAAP requires the use of estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses in the condensed consolidated financial statements and accompanying notes. We base our estimates and judgments on historical information and on various other assumptions that we believe are reasonable under the circumstances. Our actual results may differ from these estimates. U.S. GAAP requires us to make estimates and judgments in several areas, including, but not limited to: (1) the recognition of revenue and particularly the determination as to whether revenue should be reported on a gross or a net basis; (2) the evaluation of our trade receivables and the recognition of a valuation allowance for doubtful accounts; (3) the recognition and measurement of goodwill and intangible assets and particularly costs capitalized in relation to our customized internal-use software; (4) the measurement of share-based compensation and (5) the tax provision determination and particularly the estimate of our annual effective tax rate. |
Recently Issued Accounting Standards | Accounting Pronouncements adopted in 2017 From January 1, 2017, we adopted ASU 2016-09, Compensation-Stock Compensation (Topic 718): Improvement to Employee Share-based Payment Accounting issued by the Financial Accounting Standards Board (FASB), which among other items, simplifies certain aspects of the accounting for share-based payment transactions to employees. The new standard particularly requires excess tax benefits and tax deficiencies to be recorded in the statements of income as a component of the provision for income taxes when stock awards vest or are settled. The effective date is January 1, 2017. Upon adoption, a cumulative effect of $10.0 million of this change has been recognized through retained earnings. The adoption of the standard also resulted in a current year tax expense of $0.8 million which previously would have been recognized in the current period in additional paid-in capital. Accounting Pronouncements not yet adopted In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805) ("ASU 2017-01") the purpose of which is to change the definition of a business to assist entities in evaluating when a set of transferred assets and activities is a business. This update will be effective for annual periods beginning after December 15, 2017, including interim periods within those periods. The adoption of ASU 2017-01 is not expected to have a material impact on our financial position or results of operations. In January 2017, the FASB issued ASU 2017-04 Goodwill and Other (Topic 350). ASU 2017-04 simplifies the subsequent measurement of goodwill and reduces the cost and complexity of evaluating goodwill for impairment. It eliminates the need for entities to calculate the implied fair value of goodwill by assigning the fair value of a reporting unit to all of its assets and liabilities as if that reporting unit had been acquired in a business combination. Under this amendment, an entity will perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge is recognized for the amount by which the carrying value exceeds the reporting unit's fair value. This update will be effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. The adoption of ASU 2017-04 is not expected to have a material impact on our financial position or results of operations. In March 2017, FASB issued ASU 2017-07 Compensation-Retirements Benefits (Topic 715). ASU 2017-07 requires that an employer disaggregate the service cost component from the other components of net benefit cost. The amendments also provide explicit guidance on how to present the service cost component and the other components of net benefit cost in the income statement and allow only the service cost component of net benefit cost to be eligible for capitalization. The amendments in ASU 2017-07 improve the consistency, transparency, and usefulness of financial information to users that have communicated that the service cost component generally is analyzed differently from the other components of net benefit cost. This update will be effective for annual periods beginning after December 15, 2017, including interim periods within those annual periods. The amendments in ASU 2017-07 should be applied retrospectively for the presentation of the service cost component and the other components of net periodic pension cost and net periodic post-retirement benefit cost in the income statement and prospectively, on and after the effective date, for the capitalization of the service cost component of net periodic pension cost and net periodic post-retirement benefit in assets. We intend to adopt the standard on the effective date of January 1, 2018. The adoption of ASU 2017-07 is not expected to have a material impact on our financial position or results of operations. |
Financial Instruments (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedules of concentration of risk | The maximum exposure to credit risk at the end of each reported period is represented by the carrying amount of financial assets, and summarized in the following table:
For each period presented, the aging of trade receivables and allowances for potential losses is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of financial liabilities | Financial Liabilities
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of assets and liabilities carried at fair value |
|
Trade Receivables (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Receivables [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedules of trade receivables net book value and Changes in allowance for doubtful accounts | The following table shows the breakdown in trade receivables net book value for the presented periods:
Changes in allowance for doubtful accounts are summarized below:
|
Other Current Assets (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of other current assets net book value | The following table shows the breakdown in other current assets net book value for the presented periods:
|
Intangible Assets (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of finite-lived intangible assets | The amounts shown below may change in the near term as management continues to assess the fair value of acquired assets and liabilities within the twelve-month purchase price allocation period.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of estimated future amortization expense related to intangible assets | The estimated amortization expense related to intangible assets for the next five years and thereafter is as follows:
|
Goodwill (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||
Schedule of Goodwill |
|
Other Current Liabilities (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Liabilities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other current liabilities | Other current liabilities are presented in the following table:
|
Financial Liabilities (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of changes in current and non-current financial liabilities | The changes in current and non-current financial liabilities during the period ended March 31, 2016 are illustrated in the following schedules:
(1) Includes reclassification from non-current to current portion based on maturity of the financial liabilities. |
Share-Based Compensatoin (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of share-based compensation by share-based payment award | Change in Number of BSPCE/OSA/RSU/BSA
Breakdown of the Closing Balance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of share-based compensation reconciliation with the Consolidated Statements of Income | Reconciliation with the Consolidated Statements of Income
|
Financial Income and Expenses (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Income and Expenses [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Financial income (expense) | The condensed consolidated statements of income line item “Financial income (expense)” can be broken down as follows:
|
Income Taxes (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Provision for income taxes | The condensed consolidated statements of income line item “Provision for income taxes” can be broken down as follows:
|
Earnings Per Share (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of basic earnings per share |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of diluted earnings per share |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of weighted average number of anti-dilutive securities | The weighted average number of securities that were anti-dilutive for diluted EPS for the periods presented but which could potentially dilute EPS in the future are as follows:
|
Commitments and contingencies (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Changes in provisions for contingencies | Changes in provisions during the presented periods are summarized below:
|
Breakdown of Revenue and Non-Current Assets by Geographical Areas (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of consolidated revenue for each geographical area | The following tables disclose our consolidated revenue for each geographical area for each of the reported periods. Revenue by geographical area is based on the location of advertisers’ campaigns.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of revenue generated in other significant countries | Revenue generated in other significant countries where we operate is presented in the following table:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of non-current assets by geographical area and country | For each reported period, non-current assets (corresponding to the net book value of tangible and intangible assets) are presented in the table below. The geographical information results from the locations of legal entities.
|
Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
Dec. 31, 2016 |
|
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||
Income tax expense | $ 4,201 | $ 7,944 | |
Additional Paid-in Capital | Accounting Standards Update 2016-09 | |||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||
Cumulative effect of new accounting principle in period of adoption | $ 10,000 | ||
Income tax expense | $ 800 |
Significant Events and Transactions of the Period (Details) - EUR (€) |
Mar. 29, 2017 |
Mar. 28, 2017 |
---|---|---|
RCF | Multicurrency revolving facility agreement | Revolving credit facility | ||
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract] | ||
Revolving credit facility, maximum borrowing capacity | € 350,000,000.0 | € 250,000,000.0 |
Financial Instruments - Credit Risks (Details) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2017 |
Dec. 31, 2016 |
|
Concentration Risk [Line Items] | ||
Allowance for doubtful accounts receivable, period increase (decrease) | $ 1,500 | $ 5,400 |
Credit Concentration Risk | ||
Concentration Risk [Line Items] | ||
Maximum exposure | 732,113 | 756,872 |
Carrying Value | Cash and cash equivalents | ||
Concentration Risk [Line Items] | ||
Maximum exposure | 303,813 | 270,317 |
Carrying Value | Trade receivables, net of allowances | ||
Concentration Risk [Line Items] | ||
Maximum exposure | 340,837 | 397,244 |
Carrying Value | Other taxes | ||
Concentration Risk [Line Items] | ||
Maximum exposure | 44,834 | 52,942 |
Carrying Value | Other current assets | ||
Concentration Risk [Line Items] | ||
Maximum exposure | 22,772 | 19,340 |
Carrying Value | Financial assets | ||
Concentration Risk [Line Items] | ||
Maximum exposure | $ 19,857 | $ 17,029 |
Financial Instruments - Trade Receivables (Details) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2017 |
Dec. 31, 2016 |
|
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Gross value | $ 354,066 | $ 408,842 |
Allowance | (13,229) | (11,598) |
Not yet due | ||
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Gross value | 232,460 | 265,600 |
Allowance | (735) | 0 |
0 - 30 days | ||
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Gross value | 70,289 | 92,163 |
Allowance | (360) | (49) |
31 - 60 days | ||
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Gross value | 16,196 | 19,747 |
Allowance | (628) | (182) |
61 - 90 days | ||
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Gross value | 8,022 | 6,055 |
Allowance | (380) | (191) |
Greater than 90 days | ||
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Gross value | 27,099 | 25,277 |
Allowance | $ (11,126) | $ (11,176) |
Accounts Receivable | ||
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Concentration risk, percentage | 100.00% | 100.00% |
Accounts Receivable | Not yet due | ||
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Concentration risk, percentage | 65.50% | 65.00% |
Accounts Receivable | 0 - 30 days | ||
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Concentration risk, percentage | 19.90% | 22.50% |
Accounts Receivable | 31 - 60 days | ||
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Concentration risk, percentage | 4.60% | 4.80% |
Accounts Receivable | 61 - 90 days | ||
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Concentration risk, percentage | 2.30% | 1.50% |
Accounts Receivable | Greater than 90 days | ||
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Concentration risk, percentage | 7.70% | 6.20% |
Allowance for Doubtful Accounts | ||
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Concentration risk, percentage | 100.10% | 100.00% |
Allowance for Doubtful Accounts | Not yet due | ||
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Concentration risk, percentage | 5.60% | 0.00% |
Allowance for Doubtful Accounts | 0 - 30 days | ||
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Concentration risk, percentage | 2.70% | 0.40% |
Allowance for Doubtful Accounts | 31 - 60 days | ||
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Concentration risk, percentage | 4.70% | 1.60% |
Allowance for Doubtful Accounts | 61 - 90 days | ||
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Concentration risk, percentage | 2.90% | 1.60% |
Allowance for Doubtful Accounts | Greater than 90 days | ||
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
Concentration risk, percentage | 84.20% | 96.40% |
Financial Instruments - Financial Liabilities (Details) - USD ($) $ in Thousands |
Mar. 31, 2017 |
Dec. 31, 2016 |
---|---|---|
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
of which derivative financial instruments | $ 4,186 | $ 1,968 |
Carrying Value | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Trade payables | 295,602 | 365,788 |
Other taxes | 41,414 | 44,831 |
Employee-related payables | 53,862 | 55,874 |
Other current liabilities | 35,032 | 30,221 |
Financial liabilities | 87,018 | 85,580 |
of which derivative financial instruments | 4,186 | 1,968 |
Total | 512,928 | 582,294 |
Fair value | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Trade payables | 295,602 | 365,788 |
Other taxes | 41,414 | 44,831 |
Employee-related payables | 53,862 | 55,874 |
Other current liabilities | 35,032 | 30,221 |
Financial liabilities | 87,018 | 85,580 |
of which derivative financial instruments | 4,186 | 1,968 |
Total | $ 512,928 | $ 582,294 |
Financial Instruments - Cash and Cash Equivalents (Details) - USD ($) $ in Thousands |
Mar. 31, 2017 |
Dec. 31, 2016 |
---|---|---|
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | $ 303,813 | $ 270,317 |
Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 216,436 | 182,226 |
Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 87,377 | 88,091 |
Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 0 | 0 |
Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 0 | 31,688 |
Money market funds | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 0 | 31,688 |
Money market funds | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 0 | 0 |
Money market funds | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 0 | 0 |
Interest-bearing bank deposits | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 87,377 | 88,091 |
Interest-bearing bank deposits | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 0 | 0 |
Interest-bearing bank deposits | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 87,377 | 88,091 |
Interest-bearing bank deposits | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 0 | 0 |
Cash and cash equivalents | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 216,436 | 150,538 |
Cash and cash equivalents | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 216,436 | 150,538 |
Cash and cash equivalents | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 0 | 0 |
Cash and cash equivalents | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | $ 0 | $ 0 |
Trade Receivables (Details) - USD ($) $ in Thousands |
Mar. 31, 2017 |
Dec. 31, 2016 |
Mar. 31, 2016 |
Dec. 31, 2015 |
---|---|---|---|---|
Receivables [Abstract] | ||||
Trade accounts receivables | $ 354,066 | $ 408,842 | ||
(Less) Allowance for doubtful accounts | (13,229) | (11,598) | $ (6,951) | $ (6,264) |
Net book value at end of period | $ 340,837 | $ 397,244 |
Trade Receivables - Allowance for Doubtful Accounts Rollforward (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
|
Allowance for Doubtful Accounts Receivable [Roll Forward] | ||
Balance at January 1 | $ (11,598) | $ (6,264) |
Allowance for doubtful accounts | (3,686) | (906) |
Reversal of provision | 2,142 | 366 |
Currency translation adjustment | (87) | (147) |
Balance at March 31 | $ (13,229) | $ (6,951) |
Other Current Assets (Details) - USD ($) $ in Thousands |
Mar. 31, 2017 |
Dec. 31, 2016 |
---|---|---|
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | ||
Prepayments to suppliers | $ 4,114 | $ 2,439 |
Other debtors | 2,816 | 3,263 |
Prepaid expenses | 15,842 | 13,638 |
Gross book value at end of period | 22,772 | 19,340 |
Net book value at end of period | $ 22,772 | $ 19,340 |
Intangible Assets - Schedule of Finite-lived Intangible Assets (Details) - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2017 |
Dec. 31, 2016 |
|
Finite-Lived Intangible Assets [Line Items] | ||
Amounts recognized as of acquisition date | $ 93.0 | $ 84.4 |
Technology-Based Intangible Assets | ||
Finite-Lived Intangible Assets [Line Items] | ||
Amounts recognized as of acquisition date | $ 15.3 | 24.4 |
Weighted-average useful lives (in years) | 3 years | |
Technology-Based Intangible Assets | Minimum | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted-average useful lives (in years) | 3 years | |
Technology-Based Intangible Assets | Maximum | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted-average useful lives (in years) | 5 years | |
Customer Relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Amounts recognized as of acquisition date | $ 77.7 | $ 60.0 |
Weighted-average useful lives (in years) | 9 years | |
Customer Relationships | Minimum | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted-average useful lives (in years) | 5 years | |
Customer Relationships | Maximum | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted-average useful lives (in years) | 9 years |
Intangible Assets - Estimated Amortization Expense (Details) $ in Thousands |
Mar. 31, 2017
USD ($)
|
---|---|
Finite-Lived Intangible Assets [Line Items] | |
From April 1, to December 31, 2017 | $ 16,643 |
2018 | 21,368 |
2019 | 17,239 |
2020 | 9,906 |
2021 | 9,017 |
Thereafter | 33,789 |
Total | 107,962 |
Software | |
Finite-Lived Intangible Assets [Line Items] | |
From April 1, to December 31, 2017 | 4,436 |
2018 | 5,246 |
2019 | 3,091 |
2020 | 1,278 |
2021 | 389 |
Thereafter | 0 |
Total | 14,440 |
Technology and customer relationships | |
Finite-Lived Intangible Assets [Line Items] | |
From April 1, to December 31, 2017 | 12,207 |
2018 | 16,122 |
2019 | 14,148 |
2020 | 8,628 |
2021 | 8,628 |
Thereafter | 33,789 |
Total | $ 93,522 |
Goodwill (Details) $ in Thousands |
3 Months Ended |
---|---|
Mar. 31, 2017
USD ($)
| |
Goodwill [Roll Forward] | |
Balance at January 1, 2017 | $ 209,418 |
Additions to goodwill | 22,327 |
Currency translation adjustment | 393 |
Balance at March 31, 2017 | $ 232,138 |
Other Current Liabilities (Details) - USD ($) $ in Thousands |
Mar. 31, 2017 |
Dec. 31, 2016 |
---|---|---|
Other Liabilities Disclosure [Abstract] | ||
Clients' prepayments | $ 12,816 | $ 9,176 |
Accounts payable relating to capital expenditures | 10,657 | 15,484 |
Other creditors | 10,232 | 2,440 |
Accounts payable relating to capital expenditures | 1,327 | 3,121 |
Accounts Payable, Accrued Liabilities, Employee-related Payables, and Taxes Payable, Current | $ 35,032 | $ 30,221 |
Financial Liabilities - Changes in Current and Non-Current Financial Liabilities (Details) $ in Thousands |
3 Months Ended |
---|---|
Mar. 31, 2017
USD ($)
| |
Financial Liabilities Activity [Roll Forward] | |
Borrowings, Current portion, Beginning balance | $ 5,524 |
Other financial liabilities, Current portion, Beginning balance | 477 |
Derivative instruments, Current portion, Beginning balance | 1,968 |
Financial liabilities, Current portion, Beginning balance | 7,969 |
Borrowings, Non current portion, Beginning balance | 77,397 |
Other financial liabilities, Non current portion, Beginning balance | 214 |
Financial liabilities, Non current portion, Beginning balance | 77,611 |
Borrowings, Beginning balance | 82,921 |
Other financial liabilities, Beginning balance | 691 |
Derivative instruments, Beginning balance | 1,968 |
Financial liabilities, Beginning balance | 85,580 |
New borrowings | 360 |
Repayments of financial liabilities | (2,294) |
Change in scope | 0 |
Other | 2,184 |
Currency translation adjustment | 1,188 |
Borrowings, Current portion, Ending balance | 80,069 |
Other financial liabilities, Current portion, Ending balance | 143 |
Derivative instruments, Current portion, Ending balance | 4,186 |
Financial liabilities, Current portion, Ending balance | 84,398 |
Borrowings, Non current portion, Ending balance | 1,947 |
Other financial liabilities, Non current portion, Ending balance | 673 |
Financial liabilities, Non current portion, Ending balance | 2,620 |
Borrowings, Ending balance | 82,016 |
Other financial liabilities, Ending balance | 816 |
Derivative instruments, Ending balance | 4,186 |
Financial liabilities, Ending balance | 87,018 |
Borrowings | |
Financial Liabilities Activity [Roll Forward] | |
New borrowings | 0 |
Repayments of borrowings | (2,053) |
Change in scope | 0 |
Other | 0 |
Currency translation adjustment | 1,148 |
Other financial liabilities | |
Financial Liabilities Activity [Roll Forward] | |
New borrowings | 360 |
Repayments of other financial liabilities | (241) |
Change in scope | 0 |
Other | 3 |
Currency translation adjustment | 3 |
Financial derivatives | |
Financial Liabilities Activity [Roll Forward] | |
Change in scope | 0 |
Other | 2,181 |
Currency translation adjustment | 37 |
Financial liabilities, Current portion | |
Financial Liabilities Activity [Roll Forward] | |
New borrowings | 0 |
Repayments of financial liabilities | (2,294) |
Change in scope | 0 |
Other | 78,631 |
Currency translation adjustment | 92 |
Financial liabilities, Current portion | Borrowings | |
Financial Liabilities Activity [Roll Forward] | |
New borrowings | 0 |
Repayments of borrowings | (2,053) |
Change in scope | 0 |
Other | 76,546 |
Currency translation adjustment | 52 |
Financial liabilities, Current portion | Other financial liabilities | |
Financial Liabilities Activity [Roll Forward] | |
New borrowings | 0 |
Repayments of other financial liabilities | (241) |
Change in scope | 0 |
Other | (96) |
Currency translation adjustment | 3 |
Financial liabilities, Current portion | Financial derivatives | |
Financial Liabilities Activity [Roll Forward] | |
Change in scope | 0 |
Other | 2,181 |
Currency translation adjustment | 37 |
Financial liablities, Non current portion | |
Financial Liabilities Activity [Roll Forward] | |
New borrowings | 360 |
Repayments of financial liabilities | 0 |
Change in scope | 0 |
Other | (76,447) |
Currency translation adjustment | 1,096 |
Financial liablities, Non current portion | Borrowings | |
Financial Liabilities Activity [Roll Forward] | |
New borrowings | 0 |
Repayments of borrowings | 0 |
Change in scope | 0 |
Other | (76,546) |
Currency translation adjustment | 1,096 |
Financial liablities, Non current portion | Other financial liabilities | |
Financial Liabilities Activity [Roll Forward] | |
New borrowings | 360 |
Repayments of other financial liabilities | 0 |
Change in scope | 0 |
Other | 99 |
Currency translation adjustment | $ 0 |
Financial Liabilities - Additional Information (Details) - Revolving credit facility - RCF $ in Millions |
Mar. 31, 2017
CNY (¥)
|
Mar. 31, 2017
USD ($)
|
Mar. 29, 2017
CNY (¥)
|
Mar. 29, 2017
EUR (€)
|
Mar. 28, 2017
CNY (¥)
|
Mar. 28, 2017
EUR (€)
|
---|---|---|---|---|---|---|
Multicurrency revolving facility agreement | ||||||
Debt Instrument [Line Items] | ||||||
Revolving credit facility, maximum borrowing capacity | € 350,000,000.0 | € 250,000,000.0 | ||||
HSBC revolving loan facility | ||||||
Debt Instrument [Line Items] | ||||||
Revolving credit facility, maximum borrowing capacity | ¥ 50,000,000 | $ 7.3 | ¥ 50,000,000.0 | ¥ 40,000,000.0 |
Share-Based Compensatoin - Narrative (Details) |
3 Months Ended | |
---|---|---|
Mar. 01, 2017
shares
|
Mar. 31, 2017
grant
shares
|
|
RSUs | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
RSUs granted (in shares) | 231,460 | |
OSA/BSPCE | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Options granted (in shares) | 0 | |
BSAs | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Number of grants | grant | 1 | |
Options granted (in shares) | 10,825 | 10,825 |
Senior management | RSUs | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
RSUs granted (in shares) | 231,460 |
Share-Based Compensatoin - Change in Number of BSPCE/OSA/RSU/BSA (Details) - shares |
3 Months Ended | |
---|---|---|
Mar. 01, 2017 |
Mar. 31, 2017 |
|
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments [Roll Forward] | ||
Beginning balance (in shares) | 8,391,496 | |
Granted (in shares) | 242,285 | |
Exercised (in shares) | (687,433) | |
Forfeited (in shares) | (120,974) | |
Expired (in shares) | 0 | |
Ending balance (in shares) | 7,825,374 | |
OSA/BSPCE | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ||
Beginning balance, options (in shares) | 4,960,092 | |
Granted, options (in shares) | 0 | |
Exercised, options (in shares) | (671,993) | |
Forfeited, options (in shares) | (44,597) | |
Expired, options (in shares) | 0 | |
Ending balance, options (in shares) | 4,243,502 | |
RSU | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ||
Beginning balance (in shares) | 3,243,279 | |
Granted (in shares) | 231,460 | |
Forfeited (in shares) | (76,377) | |
Ending balance (in shares) | 3,398,362 | |
BSAs | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ||
Beginning balance, options (in shares) | 188,125 | |
Granted, options (in shares) | 10,825 | 10,825 |
Exercised, options (in shares) | (15,440) | |
Forfeited, options (in shares) | 0 | |
Expired, options (in shares) | 0 | |
Ending balance, options (in shares) | 183,510 |
Share-Based Compensatoin - Breakdown of the Closing Balance (Details) - € / shares |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Dec. 31, 2016 |
|
OSA/BSPCE | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Number outstanding, options (in shares) | 4,243,502 | 4,960,092 |
Weighted-average exercise price, options (in Euro per share) | € 24.67 | |
Number exercisable, options (in shares) | 2,326,206 | |
Weighted-average exercise price, options (in Euro per share) | € 18.69 | |
Weighted-average remaining contractual life of options outstanding, in years | 7 years 2 months 12 days | |
RSU | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Number outstanding (in shares) | 3,398,362 | 3,243,279 |
Number exercisable (in shares) | 10,460 | |
BSAs | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Number outstanding, options (in shares) | 183,510 | 188,125 |
Weighted-average exercise price, options (in Euro per share) | € 19.68 | |
Number exercisable, options (in shares) | 112,435 | |
Weighted-average exercise price, options (in Euro per share) | € 11.76 | |
Weighted-average remaining contractual life of options outstanding, in years | 7 years 1 month 17 days |
Share-Based Compensatoin - Share-based compensation expense (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
|
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | $ (14,583) | $ (8,281) |
Total equity awards compensation expense | (14,940) | (8,370) |
R&D | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | (3,916) | (2,402) |
Total equity awards compensation expense | (3,916) | (2,402) |
S&O | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | (6,710) | (3,390) |
Total equity awards compensation expense | (6,710) | (3,390) |
G&A | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | (3,957) | (2,489) |
Total equity awards compensation expense | (4,314) | (2,578) |
RSUs | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | (12,460) | (4,025) |
RSUs | R&D | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | (3,472) | (1,256) |
RSUs | S&O | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | (6,260) | (1,668) |
RSUs | G&A | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | (2,728) | (1,101) |
Share options / BSPCE | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | (2,123) | (4,256) |
Share options / BSPCE | R&D | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | (444) | (1,146) |
Share options / BSPCE | S&O | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | (450) | (1,722) |
Share options / BSPCE | G&A | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Share-based compensation expense | (1,229) | (1,388) |
BSAs | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Issuance of Stock and Warrants for Services or Claims | (357) | (89) |
BSAs | R&D | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Issuance of Stock and Warrants for Services or Claims | 0 | 0 |
BSAs | S&O | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Issuance of Stock and Warrants for Services or Claims | 0 | 0 |
BSAs | G&A | ||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||
Issuance of Stock and Warrants for Services or Claims | $ (357) | $ (89) |
Financial Income and Expenses - Financial income (expense) (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
|
Other Income and Expenses [Abstract] | ||
Financial income from cash equivalents | $ 248 | $ 388 |
Interest and fees | (757) | (476) |
Interest on debt | (568) | (270) |
Fees | (189) | (206) |
Foreign exchange gain (loss) | (1,808) | (1,216) |
Other financial expense | (16) | (13) |
Total financial income (expense) | $ (2,333) | $ (1,317) |
Financial Income and Expenses - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
|
Other Income and Expenses [Abstract] | ||
Financial income (expense) | $ 2,333 | $ 1,317 |
Income Taxes - Breakdown of Income Taxes (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
|
Income Tax Disclosure [Abstract] | ||
Current income tax | $ (11,071) | $ (9,082) |
France | (4,572) | (3,121) |
International | (6,499) | (5,961) |
Net change in deferred taxes | 6,870 | 1,138 |
France | 601 | 1,216 |
International | 6,269 | (78) |
Provision for income taxes | $ (4,201) | $ (7,944) |
Estimated tax rate | 29.00% | 30.00% |
Effective tax rate | 22.00% | 30.00% |
Earnings Per Share - Basic Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
|
Earnings Per Share [Abstract] | ||
Net income attributable to shareholders of Criteo S.A. | $ 12,442 | $ 17,131 |
Weighted average number of shares outstanding (in shares) | 64,189,194 | 62,610,013 |
Basic earnings per share (in USD per share) | $ 0.19 | $ 0.27 |
Earnings Per Share - Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
|
Earnings Per Share [Abstract] | ||
Net income attributable to shareholders of Criteo S.A. | $ 12,442 | $ 17,131 |
Weighted average number of shares outstanding (in shares) | 64,189,194 | 62,610,013 |
Dilutive effect of : | ||
Restricted share units (RSU's) (in shares) | 1,277,928 | 0 |
Share options and employee warrants (BSPCEs) (in shares) | 1,722,009 | 2,144,884 |
Non-employees warrants (BSAs) (in shares) | 93,881 | 86,237 |
Weighted average number of shares outstanding used to determine diluted earnings per share (in shares) | 67,283,012 | 64,841,134 |
Diluted earnings per share (in USD per share) | $ 0.18 | $ 0.26 |
Earnings Per Share - Weighted Average Number of Anti-Dilutive Securities (Details) - shares |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
|
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Weighted average number of anti-dilutive securities excluded from diluted earnings per share (in shares) | 672,640 | 1,038,691 |
Restricted share awards | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Weighted average number of anti-dilutive securities excluded from diluted earnings per share (in shares) | 229,730 | 1,038,691 |
Share options / BSPCE | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Weighted average number of anti-dilutive securities excluded from diluted earnings per share (in shares) | 442,910 | 0 |
BSAs | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Weighted average number of anti-dilutive securities excluded from diluted earnings per share (in shares) | 0 | 0 |
Commitments and contingencies - Commitments (Details) |
3 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017
USD ($)
|
Mar. 31, 2016
USD ($)
|
Mar. 31, 2017
CNY (¥)
|
Mar. 31, 2017
EUR (€)
|
Mar. 31, 2017
USD ($)
|
Mar. 29, 2017
CNY (¥)
|
Mar. 29, 2017
EUR (€)
|
Mar. 28, 2017
CNY (¥)
|
Mar. 28, 2017
EUR (€)
|
|
Commitments and Contingencies Disclosure [Abstract] | |||||||||
Operating lease expenses | $ 8,800,000 | $ 7,400,000 | |||||||
Hosting costs | $ 13,900,000 | $ 9,300,000 | |||||||
Revolving credit facility | RCF | HSBC revolving loan facility | |||||||||
Debt Instrument [Line Items] | |||||||||
Revolving credit facility, maximum borrowing capacity | ¥ 50,000,000 | $ 7,300,000 | ¥ 50,000,000.0 | ¥ 40,000,000.0 | |||||
Long-term line of credit | ¥ 25,000,000 | 3,600,000 | |||||||
Revolving credit facility | RCF | Bank syndicate RCF | |||||||||
Debt Instrument [Line Items] | |||||||||
Revolving credit facility, maximum borrowing capacity | € 350,000,000.0 | 374,200,000.0 | |||||||
Long-term line of credit | $ 75,000,000 | ||||||||
Revolving credit facility | RCF | Multicurrency revolving facility agreement | |||||||||
Debt Instrument [Line Items] | |||||||||
Revolving credit facility, maximum borrowing capacity | € | € 350,000,000.0 | € 250,000,000.0 |
Commitments and contingencies - Contingencies (Details) $ in Thousands |
3 Months Ended |
---|---|
Mar. 31, 2017
USD ($)
| |
Loss Contingency Accrual [Roll Forward] | |
Contingencies accrual, beginning balance | $ 654 |
Charges | 528 |
Provision used | (197) |
Provision released not used | (16) |
Currency translation adjustments | 11 |
Contingencies accrual, ending balance | 980 |
Contingencies accrual, of which current | 980 |
Provision for employee-related litigation | |
Loss Contingency Accrual [Roll Forward] | |
Contingencies accrual, beginning balance | 485 |
Charges | 12 |
Provision used | (197) |
Provision released not used | (16) |
Currency translation adjustments | 6 |
Contingencies accrual, ending balance | 290 |
Contingencies accrual, of which current | 290 |
Other provisions | |
Loss Contingency Accrual [Roll Forward] | |
Contingencies accrual, beginning balance | 169 |
Charges | 516 |
Provision used | 0 |
Provision released not used | 0 |
Currency translation adjustments | 5 |
Contingencies accrual, ending balance | 690 |
Contingencies accrual, of which current | $ 690 |
Breakdown of Revenue and Non-Current Assets by Geographical Areas - Revenue by Geographical Area (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
|
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Revenue | $ 516,667 | $ 401,253 |
Americas | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Revenue | 208,013 | 147,174 |
EMEA | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Revenue | 189,092 | 159,405 |
Asia-Pacific | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Revenue | $ 119,562 | $ 94,674 |
Breakdown of Revenue and Non-Current Assets by Geographical Areas - Narrative (Details) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2017
USD ($)
market
|
Mar. 31, 2016
USD ($)
|
|
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Number of geographical markets | market | 3 | |
Revenue | $ 516,667 | $ 401,253 |
France | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Revenue | $ 37,500 | $ 32,500 |
Breakdown of Revenue and Non-Current Assets by Geographical Areas - Revenue by Significant Other Countries (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
|
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Revenue | $ 516,667 | $ 401,253 |
United States | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Revenue | 179,663 | 126,913 |
Germany | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Revenue | 42,614 | 33,696 |
United Kingdom | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Revenue | 28,197 | 28,509 |
Japan | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Revenue | $ 85,310 | $ 65,973 |
Breakdown of Revenue and Non-Current Assets by Geographical Areas - Other Information (Details) - USD ($) $ in Thousands |
Mar. 31, 2017 |
Dec. 31, 2016 |
---|---|---|
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Non-current assets | $ 223,377 | $ 211,525 |
Americas | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Non-current assets | 134,705 | 123,308 |
United States | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Non-current assets | 133,969 | 42,474 |
Europe | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Non-current assets | 7,150 | 7,132 |
Asia-Pacific | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Non-current assets | 22,852 | 26,033 |
Japan | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Non-current assets | 7,897 | 8,965 |
Holding | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Non-current assets | $ 58,670 | $ 55,052 |
Subsequent Events (Details) $ in Millions |
Apr. 29, 2017
USD ($)
|
---|---|
Revolving credit facility | RCF | Subsequent Event | |
Subsequent Event [Line Items] | |
Repayments of Debt | $ 75 |
MCMPR!V
M$R5.HN2>:+\B2MY+Y!"^282=1/B>Z&%%A-]+Y!"ZB=#B2I@1]8V(<]M)[\25
MOEWV#M2<*]!%@XVNU^BI. <4:F6V.[T7XVP8 \7[:>RA>?;F?P%02P,$%
M @ 9(*J2EC[\26J P 5 \ !@ !X;"]W;W)KJATG>>&=!_8VB6_R%CY.^P]N&Z$=.1N/
M+QO[7QOC :5LKG"$6OQ@LR&A]N%X@V<[CMEH>---/XC-W[CX"U!+ P04
M" !D@JI*J9]%I+,! #2 P &0 'AL+W=O801;0! #2 P &0 'AL+W=O
"YSB
M=\5!R757:9
MBB<:+_X=/HW4-V9:KBRZ:.>?3[SD1FL'WLKFP7OI_!0O@8#&A>VCWYOI+4^!
MT_T\IF3YKRC_ E!+ P04 " !D@JI*3=@O4+@! #2 P &0 'AL+W=O
M
Q)">>]E
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M)]_JT